Kantarjian, H. et al. Acute myeloid leukemia: current progress and future directions. Blood Cancer J. 11, 41 (2021).
Google Scholar
Mueller, B. U., Seipel, K., Bacher, U. & Pabst, T. Autologous transplantation for older adults with AML. Cancers 10, 340 (2018).
Google Scholar
Thomas, S. et al. Targeting the Bcl-2 family for cancer therapy. Expert Opin. Ther. Targets 17, 61–75 (2013).
Google Scholar
Roberts, A. W., Wei, A. H. & Huang, D. C. S. BCL2 and MCL1 inhibitors for hematologic malignancies. Blood 138, 1120–1136 (2021).
Google Scholar
Montero, J. & Haq, R. Adapted to survive: targeting cancer cells with BH3 mimetics. Cancer Discov. 12, 1217–1232 (2022).
Google Scholar
Moujalled, D. M. et al. Acquired mutations in BAX confer resistance to BH3-mimetic therapy in acute myeloid leukemia. Blood 141, 634–644 (2023).
Google Scholar
Stevens, B. M. et al. Fatty acid metabolism underlies venetoclax resistance in acute myeloid leukemia stem cells. Nat. Cancer 1, 1176–1187 (2020).
Google Scholar
Glytsou, C. et al. Mitophagy promotes resistance to BH3 mimetics in acute myeloid leukemia. Cancer Discov. 13, 1656–1677 (2023).
Google Scholar
Jones, C. L. et al. Nicotinamide metabolism mediates resistance to venetoclax in relapsed acute myeloid leukemia stem cells. Cell Stem Cell 27, 748–764 e744 (2020).
Google Scholar
Chen, X. et al. Targeting mitochondrial structure sensitizes acute myeloid leukemia to venetoclax treatment. Cancer Discov. 9, 890–909 (2019).
Google Scholar
Pei, S. et al. A novel type of monocytic leukemia stem cell revealed by the clinical use of venetoclax-based therapy. Cancer Discov. 13, 2032–2049 (2023).
Google Scholar
Herzig, S. & Shaw, R. J. AMPK: guardian of metabolism and mitochondrial homeostasis. Nat. Rev. Mol. Cell Biol. 19, 121–135 (2018).
Google Scholar
Saito, Y., Chapple, R. H., Lin, A., Kitano, A. & Nakada, D. AMPK protects leukemia-initiating cells in myeloid leukemias from metabolic stress in the bone marrow. Cell Stem Cell 17, 585–596 (2015).
Google Scholar
Pei, S. et al. AMPK/FIS1-mediated mitophagy is required for self-renewal of human AML stem cells. Cell Stem Cell 23, 86–100 e106 (2018).
Google Scholar
Guieze, R. et al. Mitochondrial reprogramming underlies resistance to BCL-2 inhibition in lymphoid malignancies. Cancer Cell 36, 369–384 e313 (2019).
Google Scholar
Legrand, N. et al. AMP-activated protein kinase contributes to apoptosis induced by the Bcl-2 inhibitor venetoclax in acute myeloid leukemia. Cancers 13, 5966 (2021).
Google Scholar
Pan, R. A. et al. BH3 profiling as pharmacodynamic biomarker for the activity of BH3 mimetics. Haematologica 109, 1253–1258 (2024).
Google Scholar
Kawashima, N. et al. Comparison of clonal architecture between primary and immunodeficient mouse-engrafted acute myeloid leukemia cells. Nat. Commun. 13, 1624 (2022).
Google Scholar
He, X. et al. PRMT1-mediated FLT3 arginine methylation promotes maintenance of FLT3-ITD+ acute myeloid leukemia. Blood 134, 548–560 (2019).
Google Scholar
Dong, H. et al. Targeting PRMT9-mediated arginine methylation suppresses cancer stem cell maintenance and elicits cGAS-mediated anticancer immunity. Nat. Cancer 5, 601–624 (2024).
Google Scholar
Schimmer, R. R. et al. TP53 mutations confer resistance to hypomethylating agents and BCL-2 inhibition in myeloid neoplasms. Blood Adv. 6, 3201–3206 (2022).
Google Scholar
Potter, D. S., Du, R., Bhola, P., Bueno, R. & Letai, A. Dynamic BH3 profiling identifies active BH3 mimetic combinations in non-small cell lung cancer. Cell Death Dis. 12, 741 (2021).
Google Scholar
Lin, K. H. et al. Systematic dissection of the metabolic-apoptotic interface in AML reveals heme biosynthesis to be a regulator of drug sensitivity. Cell Metab. 29, 1217–1231 e1217 (2019).
Google Scholar
Poliakova Turan, M. et al. E2F1-associated purine synthesis pathway is a major component of the MET-DNA damage response network. Cancer Res. Commun. 4, 1863–1880 (2024).
Google Scholar
Fresquet, V. et al. Endogenous retroelement activation by epigenetic therapy reverses the Warburg effect and elicits mitochondrial-mediated cancer cell death. Cancer Discov. 11, 1268–1285 (2021).
Google Scholar
Shi, J. et al. O-GlcNAcylation regulates ischemia-induced neuronal apoptosis through AKT signaling. Sci. Rep. 5, 14500 (2015).
Google Scholar
Daftuar, L., Zhu, Y., Jacq, X. & Prives, C. Ribosomal proteins RPL37, RPS15 and RPS20 regulate the Mdm2-p53-MdmX network. PLoS ONE 8, e68667 (2013).
Google Scholar
Nishida, Y. et al. Enhanced TP53 reactivation disrupts MYC transcriptional program and overcomes venetoclax resistance in acute myeloid leukemias. Sci. Adv. 9, eadh1436 (2023).
Google Scholar
Certo, M. et al. Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members. Cancer Cell 9, 351–365 (2006).
Google Scholar
Huang, H. T. et al. MELK is not necessary for the proliferation of basal-like breast cancer cells. eLife 6, e26693 (2017).
Google Scholar
Li, X. et al. Comparative molecular characterization of ADSS1 and ADSS2 genes in pig (Sus scrofa). Comp. Biochem. Physiol. B 147, 271–277 (2007).
Google Scholar
Gíslason, M. H. et al. BloodSpot 3.0: a database of gene and protein expression data in normal and malignant haematopoiesis. Nucleic Acids Res. 52, D1138–d1142 (2024).
Google Scholar
Wang, H. et al. Disruption of dNTP homeostasis by ribonucleotide reductase hyperactivation overcomes AML differentiation blockade. Blood 139, 3752–3770 (2022).
Google Scholar
Huang, F. et al. Guanosine triphosphate links MYC-dependent metabolic and ribosome programs in small-cell lung cancer. J. Clin. Invest. 131, e139929 (2021).
Google Scholar
Nam, A. S. et al. Somatic mutations and cell identity linked by genotyping of transcriptomes. Nature 571, 355–360 (2019).
Google Scholar
DiNardo, C. D. et al. Molecular patterns of response and treatment failure after frontline venetoclax combinations in older patients with AML. Blood 135, 791–803 (2020).
Google Scholar
Jeon, S. M. Regulation and function of AMPK in physiology and diseases. Exp. Mol. Med. 48, e245 (2016).
Google Scholar
Jones, R. G. et al. AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol. Cell 18, 283–293 (2005).
Google Scholar
Tibrewal, N. & Elliott, G. I. Evaluation of hadacidin analogues. Bioorg. Med. Chem. Lett. 21, 517–519 (2011).
Google Scholar
Powell, S. M., Zalkin, H. & Dixon, J. E. Cloning and characterization of the cDNA encoding human adenylosuccinate synthetase. FEBS Lett. 303, 4–10 (1992).
Google Scholar
Griessinger, E. et al. Oxidative phosphorylation fueled by fatty acid oxidation sensitizes leukemic stem cells to cold. Cancer Res. 83, 2461–2470 (2023).
Google Scholar
Jones, C. L. et al. Inhibition of amino acid metabolism selectively targets human leukemia stem cells. Cancer Cell 34, 724–740 e724 (2018).
Google Scholar
Hou, S., Liu, J. & Zhu, Y. Multi-omics advances for molecular characterization, precision medicine, and prognostic implications in leukemia. Cell Investig. 1, 100007 (2025).
Google Scholar
Jia, C., Liang, Z., Yao, X., Lin, Q. & Zhang, Y. CRISPR libraries: a powerful screening tool for function and mechanism study of cancer. Cell Investig. 1, 100044 (2025).
Google Scholar
Seabright, A. P. et al. AMPK activation induces mitophagy and promotes mitochondrial fission while activating TBK1 in a PINK1-Parkin independent manner. FASEB J. 34, 6284–6301 (2020).
Google Scholar
Nakada, D., Saunders, T. L. & Morrison, S. J. Lkb1 regulates cell cycle and energy metabolism in haematopoietic stem cells. Nature 468, 653–658 (2010).
Google Scholar
Grenier, A. et al. AMPK-PERK axis represses oxidative metabolism and enhances apoptotic priming of mitochondria in acute myeloid leukemia. Cell Rep. 38, 110197 (2022).
Google Scholar
Sneyers, F. et al. Intracellular BAPTA directly inhibits PFKFB3, thereby impeding mTORC1-driven Mcl-1 translation and killing MCL-1-addicted cancer cells. Cell Death Dis. 14, 600 (2023).
Google Scholar
Satta, T. et al. Dual mTORC1/2 inhibition synergistically enhances AML cell death in combination with the BCL2 antagonist venetoclax. Clin. Cancer Res. 29, 1332–1343 (2023).
Google Scholar
Gonzalez, A., Hall, M. N., Lin, S. C. & Hardie, D. G. AMPK and TOR: the yin and yang of cellular nutrient sensing and growth control. Cell Metab. 31, 472–492 (2020).
Google Scholar
Hoxhaj, G. et al. The mTORC1 signaling network senses changes in cellular purine nucleotide levels. Cell Rep. 21, 1331–1346 (2017).
Google Scholar
Ong, F., Kim, K. & Konopleva, M. Y. Venetoclax resistance: mechanistic insights and future strategies. Cancer Drug Resist. 5, 380–400 (2022).
Google Scholar
Thijssen, R. et al. Intact TP-53 function is essential for sustaining durable responses to BH3-mimetic drugs in leukemias. Blood 137, 2721–2735 (2021).
Google Scholar
Sun, J. et al. SIRT1 activation disrupts maintenance of myelodysplastic syndrome stem and progenitor cells by restoring TET2 function. Cell Stem Cell 23, 355–369 e359 (2018).
Google Scholar
Chan, A. K. N. et al. Therapeutic targeting Tudor domains in leukemia via CRISPR-scan assisted drug discovery. Sci. Adv. 10, eadk3127 (2024).
Google Scholar
Mattson, N. M. et al. A novel class of inhibitors that disrupts the stability of integrin heterodimers identified by CRISPR-tiling-instructed genetic screens. Nat. Struct. Mol. Biol. 31, 465–475 (2024).
Google Scholar
Li, L. et al. Activation of p53 by SIRT1 inhibition enhances elimination of CML leukemia stem cells in combination with imatinib. Cancer Cell 21, 266–281 (2012).
Google Scholar
Bhatt, S. et al. Reduced mitochondrial apoptotic priming drives resistance to BH3 mimetics in acute myeloid leukemia. Cancer Cell 38, 872–890 e876 (2020).
Google Scholar
Zhang, H. et al. CDK7 inhibition potentiates genome instability triggering anti-tumor immunity in small cell lung cancer. Cancer Cell 37, 37–54 e39 (2020).
Google Scholar
Zhu, B. et al. A simultaneously quantitative method to profiling twenty endogenous nucleosides and nucleotides in cancer cells using UHPLC-MS/MS. Talanta 179, 615–623 (2018).
Google Scholar
Eberhardt, J., Santos-Martins, D., Tillack, A. F. & Forli, S. AutoDock Vina 1.2.0: new docking methods, expanded force field, and python bindings. J. Chem. Inf. Model. 61, 3891–3898 (2021).
Google Scholar
Trott, O. & Olson, A. J. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 31, 455–461 (2010).
Google Scholar
Mayer, M. & Meyer, B. Group epitope mapping by saturation transfer difference NMR to identify segments of a ligand in direct contact with a protein receptor. J. Am. Chem. Soc. 123, 6108–6117 (2001).
Google Scholar
Jafari, R. et al. The cellular thermal shift assay for evaluating drug target interactions in cells. Nat. Protoc. 9, 2100–2122 (2014).
Google Scholar
